These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 30298754

  • 1. Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.
    Jacobs NI, Montebello M, Monds LA, Lintzeris N.
    Australas Psychiatry; 2019 Feb; 27(1):80-85. PubMed ID: 30298754
    [Abstract] [Full Text] [Related]

  • 2. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
    Grover C, Monds L, Montebello M.
    Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP.
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists.
    Orjuela-Rojas JM, García Orjuela X, Ocampo Serna S.
    J Cannabis Res; 2021 Jul 05; 3(1):26. PubMed ID: 34225825
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
    Bawa Z, Saini B, McCartney D, Bedoya-Pérez M, McLachlan AJ, McGregor IS.
    Int J Clin Pharm; 2023 Apr 05; 45(2):375-386. PubMed ID: 36446995
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.
    Bawa Z, McCartney D, Manocha R, McGregor IS.
    BMC Prim Care; 2022 Dec 19; 23(1):330. PubMed ID: 36529730
    [Abstract] [Full Text] [Related]

  • 14. Substance abuse disorders: psychiatric trainees' knowledge, diagnostic skills and attitudes.
    Roche AM, Parle MD, Campbell J, Saunders JB.
    Aust N Z J Psychiatry; 1995 Dec 19; 29(4):645-52. PubMed ID: 8825828
    [Abstract] [Full Text] [Related]

  • 15. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review.
    Hordowicz M, Klimkiewicz A, Jarosz J, Wysocka M, Jastrzębska M.
    Drug Alcohol Depend; 2021 Apr 01; 221():108652. PubMed ID: 33667785
    [Abstract] [Full Text] [Related]

  • 16. Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation.
    Luckett T, Phillips J, Lintzeris N, Allsop D, Lee J, Solowij N, Martin J, Lam L, Aggarwal R, McCaffrey N, Currow D, Chye R, Lovell M, McGregor I, Agar M.
    Intern Med J; 2016 Nov 01; 46(11):1269-1275. PubMed ID: 27530738
    [Abstract] [Full Text] [Related]

  • 17. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J.
    BMC Psychiatry; 2020 Jan 16; 20(1):24. PubMed ID: 31948424
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.